ConductScience.org, home

Paper745013

Absence of "cheese effect" during deprenyl therapy: some recent studies.

Sandler M and 3 others. J Neural Transm, 1978. Cited by 36 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Absence of "cheese effect" during deprenyl therapy: some recent studies. Papers, record 745013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/745013

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Absence of "cheese effect" during deprenyl therapy: some recent studies.
PubMed
Journal
J Neural Transm
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
1.63
iCite
Revised in PubMed
2019-11-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sandler MM
2Glover VV
3Ashford AA
4Stern GMG M

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PhenethylaminesMajor topic
SelegilineMajor topic
Amphetamines
Animals
Blood Pressure
Humans
Intestines
Monoamine Oxidase
Parkinson Disease
Substrate Specificity
Swine
Tyramine

Source PubMed

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125,150The effect of urinary pH and flow rate on monoamine output.Clin Chim Acta1978https://conductscience.org/library/papers/25150PubMed
24,943,186Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor.Psychopharmacologia1970https://conductscience.org/library/papers/4943186PubMed
3637,437Isoniazid and reaction to cheese.Ann Intern Med1978https://conductscience.org/library/papers/637437PubMed
471,602Deprenyl in Parkinson's disease.Lancet1977https://conductscience.org/library/papers/71602PubMed
5834,248Dopamine is a monoamine oxidase B substrate in man.Nature1977https://conductscience.org/library/papers/834248PubMed
665,560Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study.Lancet1977https://conductscience.org/library/papers/65560PubMed
75,054,207Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: a comparison of eight mammalian species.Adv Biochem Psychopharmacol1972https://conductscience.org/library/papers/5054207PubMed
86,056,555Clinical trial of a new type promptly acting psychoenergetic agent (phenyl-isopropyl-methylpropinyl-HCl, "E-250").Acta Med Acad Sci Hung1967https://conductscience.org/library/papers/6056555PubMed
9656,120Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatment.Biochem Pharmacol1978https://conductscience.org/library/papers/656120PubMed
104,748,552Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain.J Pharmacol Exp Ther1973https://conductscience.org/library/papers/4748552PubMed
1196,466Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'.Psychopharmacology (Berl)1978https://conductscience.org/library/papers/96466PubMed
12745,017Recent observations on the clinical pharmacology of (-)deprenyl.J Neural Transm1978https://conductscience.org/library/papers/745017PubMed
13745,014On the mode of action of L-deprenyl in the human central nervous system.J Neural Transm1978https://conductscience.org/library/papers/745014PubMed
145,659,776Some observations upon a new inhibitor of monoamine oxidase in brain tissue.Biochem Pharmacol1968https://conductscience.org/library/papers/5659776PubMed
154,384,242Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.Biochem Pharmacol1968https://conductscience.org/library/papers/4384242PubMed
16728,327Deprenyl is metabolized to methamphetamine and amphetamine in man.Br J Clin Pharmacol1978https://conductscience.org/library/papers/728327PubMed
17745,011The possible mechanisms of action of (-)deprenyl in Parkinson's disease.J Neural Transm1978https://conductscience.org/library/papers/745011PubMed
18934,359Preferential deamination of dopamine by an A type monoamine oxidase in rat brain.Naunyn Schmiedebergs Arch Pharmacol1976https://conductscience.org/library/papers/934359PubMed
191,172,524The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.J Neural Transm1975https://conductscience.org/library/papers/1172524PubMed

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
28,282,815The MPTP Story.J Parkinsons Dis2017https://conductscience.org/library/papers/28282815PubMed
27,480,491The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015).Mol Psychiatry2016https://conductscience.org/library/papers/27480491PubMed
22,872,464Pressor response to oral tyramine and monoamine oxidase inhibition during treatment with ralfinamide (NW-1029).Neurotox Res2013https://conductscience.org/library/papers/22872464PubMed
22,802,692Adjunctive therapy in Parkinson's disease: the role of rasagiline.Neuropsychiatr Dis Treat2012https://conductscience.org/library/papers/22802692PubMed
21,850,574Pressor response to oral tyramine during co-administration with safinamide in healthy volunteers.Naunyn Schmiedebergs Arch Pharmacol2011https://conductscience.org/library/papers/21850574PubMed
15,537,168In vitro formation of selegiline-N-oxide as a metabolite of selegiline in human, hamster, mouse, rat, guinea-pig, rabbit and dog.Eur J Drug Metab Pharmacokinet2004https://conductscience.org/library/papers/15537168PubMed
11,607,046
Antiaging compounds: (-)deprenyl (selegeline) and (-)1-(benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective highly potent enhancer of the impulse propagation mediated release of catecholamine and serotonin in the brain.
CNS Drug Rev2001https://conductscience.org/library/papers/11607046PubMed
6,791,202Tyramine infusions and selective monoamine oxidase inhibitor treatment. I. Changes in pressor sensitivity.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6791202PubMed
6,777,463Deprenyl in the management of response fluctuations in patients with Parkinson's disease on levodopa.J Neurol Neurosurg Psychiatry1980https://conductscience.org/library/papers/6777463PubMed
6,437,857The pharmacology of Parkinson's disease: basic aspects and recent advances.Experientia1984https://conductscience.org/library/papers/6437857PubMed
3,929,314Tyramine pressor sensitivity changes during deprenyl treatment.Psychopharmacology (Berl)1985https://conductscience.org/library/papers/3929314PubMed
3,928,010Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat.Br J Pharmacol1985https://conductscience.org/library/papers/3928010PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/745013

GET https://conductscience.org/api/papers/v1/745013/authors